News_第5页_Shenyang Dasan Pharmaceutical Technology Co., Ltd.

Home


Distinguish	Title	Data
Industry Trends	CDE Issues Overseas Drug Re-Registration Guidelines — 120-Day Approval	2025-10-31
Industry Trends	MIIT Authoritatively Releases 2019 Top 100 Chinese Pharmaceutical Enterprises List!	2025-10-31
Industry Trends	CDE Issues Draft Guidelines on Manufacturing Process for TCM Compound Formulations	2025-10-31
Industry Trends	Key Precautions During the Flu Season	2025-10-31
Industry Trends	Effective Ways to Prevent Oral Ulcers?	2025-10-31
Industry Trends	HFMD: Symptoms & Prevention in Children	2025-10-31
Industry Trends	How to Prevent Hepatitis B?	2025-10-31
Company	Soaring Dragon, Riding the Wind \| 2023 Shenyang DASAN Pharmaceutical Annual Gala	2024-03-04
Industry	Oral Semaglutide Is Here! The Weight-Loss Drug Boom Is Sizzling Hot!	2024-03-01
Industry	How to choose between domestic generic drugs that have passed the consistency evaluation and original (imported) drugs?	2024-01-31
Company	Powerful Alliance \| Shenyang DASAN Pharmaceutical and Liaoning Daewoong Pharmaceutical Technology Exchange Meeting	2024-01-31
Company	International Exchange \| Korean Dasan Pharmaceutical Visits China for Exchange and Tour	2023-12-08